Estimated Effectiveness of Prior SARS-CoV-2 BA.1 or BA.2 Infection and Booster Vaccination Against Omicron BA.5 Subvariant Infection.

Jang, Eun Jung; Choe, Young June; Kim, Ryu Kyung; Lee, Sangwon; Park, Seon Kyeong; Park, Young-Joon

Jang, Eun Jung; Choe, Young June; Kim, Ryu Kyung; Lee, Sangwon; Park, Seon Kyeong; Park, Young-Joon.

Jang EJ; Korea Disease Control and Prevention Agency, Cheongju, South Korea.
Choe YJ; Korea University Anam Hospital, Seoul, South Korea.
Kim RK; Korea Disease Control and Prevention Agency, Cheongju, South Korea.
Lee S; Korea Disease Control and Prevention Agency, Cheongju, South Korea.
Park SK; Korea Disease Control and Prevention Agency, Cheongju, South Korea.
Park YJ; Korea Disease Control and Prevention Agency, Cheongju, South Korea.

JAMA Netw Open ; 6(3): e232578, 2023 03 01.

Article in English | MEDLINE | ID: covidwho-2264404

This case-control study estimates the effectiveness of prior SARS-CoV-2 BA.1 or BA.2 infection and booster vaccination against Omicron BA.5 subvariant infection.

Subject(s)

COVID-19; SARS-CoV-2; Humans; Immunization, Secondary; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines / Variants Limits: Humans Language: English Journal: JAMA Netw Open Year: 2023 Document Type: Article Affiliation country: Jamanetworkopen.2023.2578

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google